Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
MONTREAL, Oct. 31, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) ("Telesta") is pleased to announce the closing of its previously announced plan of arrangement (the...
MONTREAL, Oct. 28, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) is pleased to announce that further to the announcement of shareholder approval last Monday, a final order of...
MONTREAL, Oct. 25, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) announced at a special meeting of shareholders held earlier today (the "Meeting") that Telesta shareholders...
MONTREAL, Oct. 11, 2016 /CNW/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced that Institutional Shareholder Services Inc. ("ISS") and Glass Lewis & Co. ("Glass Lewis"), two...
(Canadian dollars, except where noted) MONTREAL, Sept. 19, 2016 /CNW/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today released its Fiscal 2016 consolidated financial statements and...
MONTREAL, Aug. 24, 2016 /CNW/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced that it has executed a binding Agreement, subject to shareholder approval, to be acquired by ProMetic ...
MONTREAL, Aug. 2, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST)(PNK: BNHLF) Telesta Therapeutics today announced concrete actions and decisions stemming from its ongoing strategic review...
(Canadian dollars, except where noted) MONTREAL, May 10, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today issued its third quarter consolidated financial statements and...
MONTREAL, April 18, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (Telesta) today announced the outcome of its Type A meeting with the U.S. Food and Drug Administration (FDA), which was held via...
MONTREAL, April 12, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced that a Type A meeting has been scheduled with the U.S. Food and Drug Administration (FDA) on...
Type A Meeting request submitted to US FDA Expenditure reductions implemented and ongoing Strategic review process initiated MONTREAL, March 9, 2016 /CNW Telbec/ - Telesta Therapeutics Inc....
(Canadian dollars, except where noted) MONTREAL, Feb. 12, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX:TST; PNK:BNHLF) today issued its second quarter consolidated financial statements and...
MONTREAL, Feb. 2, 2016 /CNW/ - Telesta Therapeutics Inc. (TSX:TST) (PNK:BNHLF) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter to Telesta's...
MONTREAL, Dec. 14, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK:BNHLF) today provided an update on the Biologics License Application (BLA) for their drug MCNA1 that the US Food and...
MONTREAL, Nov. 19, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK:BNHLF) today announced the results of the US Food and Drug Administration's (FDA) Joint Meeting of the Cellular,...
MONTREAL, Nov. 16, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) ("Telesta" or the"Corporation") today announced the voting results from its annual general meeting of...
(Canadian dollars, except where noted) MONTREAL, Nov. 12, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today issued its first quarter consolidated financial statements and...
PARIS and MONTREAL, Oct. 28, 2015 /CNW Telbec/ - Ipsen (Euronext: IPN) (ADR: IPSEY) and Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced that they have entered into an exclusive...
MONTREAL, Oct. 8, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced the engagement of Brian J. Groch as Chief Commercial Officer, a new executive position...
MONTREAL, Sept. 28 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST)(PNK: BNHLF) today announced receipt of a notice from the U.S. Food and Drug Administration (FDA) confirming that they have...
(Canadian dollars, except where noted) MONTREAL, Sept. 14, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today issued its annual consolidated financial statements and...
MONTREAL, Aug. 28 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) announced today that it has received its BLA Filing Notification for MCNA from the U.S. Food and Drug...
MONTREAL, Aug. 19, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) announced today that it has closed a private placement financing of US$28.6 million. This transaction was led...
MONTREAL, July 20, 2015 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) announced today that it has entered into an exclusive license, supply and distribution agreement with BL&H Co....
BLA for MCNA submitted electronically to the US FDA on June 29th, 2015 Manufacturing facility upgrades completed and pre-launch production planning initiated· FDA waives US$2.3 million application...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.